{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1234.49","meta":{"versionId":"8","lastUpdated":"2021-11-23T01:02:05.000-05:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"BEST System Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2021-11-23"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.49","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113762.1.4.1234.49"}],"version":"20211123","name":"InfluenzaVaccineCodesForExposureIdentification","title":"Influenza vaccine codes for exposure identification","status":"active","experimental":false,"date":"2021-11-23T01:02:05-05:00","publisher":"BEST System Steward","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: Influenza vaccine codes for identification of potential biologics-related adverse events.),(Data Element Scope: This value set may use a model element in the QDM category of Procedure/Intervention, Immunization, Medication, or Substance.),(Inclusion Criteria: Influenza vaccine codes, including CPT/HCPCS, RxNorm, and CVX.),(Exclusion Criteria: None)","compose":{"include":[{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.47"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.48"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.46"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.45"]}]},"expansion":{"identifier":"urn:uuid:3a3016ae-848b-477a-8813-af6788741d45","timestamp":"2023-12-11T00:23:14-05:00","total":90,"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1005911","display":"influenza virus vaccine, live attenuated, A-Perth-16-2009 (H3N2) strain"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1005931","display":"influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain"},{"system":"http://hl7.org/fhir/sid/cvx","version":"20231102","code":"111","display":"influenza virus vaccine, live, attenuated, for intranasal use"},{"system":"http://hl7.org/fhir/sid/cvx","version":"20231102","code":"123","display":"influenza virus vaccine, H5N1, A/Vietnam/1203/2004 (national stockpile)"},{"system":"http://hl7.org/fhir/sid/cvx","version":"20231102","code":"125","display":"Novel Influenza-H1N1-09, live virus for nasal administration"},{"system":"http://hl7.org/fhir/sid/cvx","version":"20231102","code":"126","display":"Novel influenza-H1N1-09, preservative-free, injectable"},{"system":"http://hl7.org/fhir/sid/cvx","version":"20231102","code":"127","display":"Novel influenza-H1N1-09, injectable"},{"system":"http://hl7.org/fhir/sid/cvx","version":"20231102","code":"128","display":"Novel influenza-H1N1-09, all formulations"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1303855","display":"influenza B virus vaccine, B-Wisconsin-1-2010-like virus"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1304122","display":"influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1304278","display":"influenza B virus vaccine, B-Texas-6-2011, inactivated"},{"system":"http://hl7.org/fhir/sid/cvx","version":"20231102","code":"135","display":"influenza, high dose seasonal, preservative-free"},{"system":"http://hl7.org/fhir/sid/cvx","version":"20231102","code":"140","display":"Influenza, seasonal, injectable, preservative free"},{"system":"http://hl7.org/fhir/sid/cvx","version":"20231102","code":"141","display":"Influenza, seasonal, injectable"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1427019","display":"influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1427022","display":"influenza B virus vaccine, B-Massachusetts-2-2012-like virus"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1428984","display":"influenza B virus vaccine, B-Massachusetts-2-2012 BX-51B, inactivated"},{"system":"http://hl7.org/fhir/sid/cvx","version":"20231102","code":"144","display":"seasonal influenza, intradermal, preservative free"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1442194","display":"influenza B virus vaccine, B-Massachusetts-2-2012-like virus, recombinant"},{"system":"http://hl7.org/fhir/sid/cvx","version":"20231102","code":"149","display":"influenza, live, intranasal, quadrivalent"},{"system":"http://hl7.org/fhir/sid/cvx","version":"20231102","code":"15","display":"influenza virus vaccine, split virus (incl. purified surface antigen)-retired CODE"},{"system":"http://hl7.org/fhir/sid/cvx","version":"20231102","code":"150","display":"Influenza, injectable, quadrivalent, preservative free"},{"system":"http://hl7.org/fhir/sid/cvx","version":"20231102","code":"151","display":"influenza nasal, unspecified formulation"},{"system":"http://hl7.org/fhir/sid/cvx","version":"20231102","code":"153","display":"Influenza, injectable, Madin Darby Canine Kidney, preservative free"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1541617","display":"influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus"},{"system":"http://hl7.org/fhir/sid/cvx","version":"20231102","code":"155","display":"Seasonal, trivalent, recombinant, injectable influenza vaccine, preservative free"},{"system":"http://hl7.org/fhir/sid/cvx","version":"20231102","code":"158","display":"influenza, injectable, quadrivalent, contains preservative"},{"system":"http://hl7.org/fhir/sid/cvx","version":"20231102","code":"16","display":"influenza virus vaccine, whole virus"},{"system":"http://hl7.org/fhir/sid/cvx","version":"20231102","code":"160","display":"Influenza A monovalent (H5N1), adjuvanted, National stockpile 2013"},{"system":"http://hl7.org/fhir/sid/cvx","version":"20231102","code":"161","display":"Influenza, injectable,quadrivalent, preservative free, pediatric"},{"system":"http://hl7.org/fhir/sid/cvx","version":"20231102","code":"166","display":"influenza, intradermal, quadrivalent, preservative free, injectable"},{"system":"http://hl7.org/fhir/sid/cvx","version":"20231102","code":"168","display":"Seasonal trivalent influenza vaccine, adjuvanted, preservative free"},{"system":"http://hl7.org/fhir/sid/cvx","version":"20231102","code":"171","display":"Influenza, injectable, Madin Darby Canine Kidney, preservative free, quadrivalent"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1804259","display":"influenza A virus A/Vietnam/1203/2004 (H5N1) antigen"},{"system":"http://hl7.org/fhir/sid/cvx","version":"20231102","code":"185","display":"Seasonal, quadrivalent, recombinant, injectable influenza vaccine, preservative free"},{"system":"http://hl7.org/fhir/sid/cvx","version":"20231102","code":"186","display":"Influenza, injectable, Madin Darby Canine Kidney,  quadrivalent with preservative"},{"system":"http://hl7.org/fhir/sid/cvx","version":"20231102","code":"194","display":"influenza, Southern Hemisphere, unspecified formulation"},{"system":"http://hl7.org/fhir/sid/cvx","version":"20231102","code":"197","display":"influenza, high-dose seasonal, quadrivalent, 0.7mL dose, preservative free"},{"system":"http://hl7.org/fhir/sid/cvx","version":"20231102","code":"200","display":"influenza, seasonal, Southern Hemisphere, quadrivalent, pediatric 0.25mL dose, preservative free"},{"system":"http://hl7.org/fhir/sid/cvx","version":"20231102","code":"201","display":"influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, no preservative"},{"system":"http://hl7.org/fhir/sid/cvx","version":"20231102","code":"202","display":"influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, with preservative"},{"system":"http://hl7.org/fhir/sid/cvx","version":"20231102","code":"205","display":"influenza, seasonal vaccine, quadrivalent, adjuvanted, 0.5mL dose, preservative free"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"2050418","display":"0.5 ML influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.12 MG/ML Prefilled Syringe"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"2050422","display":"Fluzone 2018-2019 Injectable Product"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"2050423","display":"0.5 ML influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.12 MG/ML Prefilled Syringe [Fluzone 2018-2019]"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"2050776","display":"Fluzone Quadrivalent 2018-2019 Injectable Product"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"2050787","display":"influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Fluzone Quadrivalent 2018-2019]"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"2177494","display":"Fluzone Quadrivalent 2019-2020 Injectable Product"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"2177503","display":"0.25 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"2177504","display":"0.25 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2019-2020]"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"2177590","display":"influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"2177592","display":"influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Fluzone Quadrivalent 2019-2020]"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"2177692","display":"0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.12 MG/ML Prefilled Syringe"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"2177696","display":"Fluzone 2019-2020 Injectable Product"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"2177697","display":"0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.12 MG/ML Prefilled Syringe [Fluzone 2019-2020]"},{"system":"http://hl7.org/fhir/sid/cvx","version":"20231102","code":"69","display":"parainfluenza-3 virus vaccine"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"857921","display":"influenza B virus vaccine B/Brisbane/60/2008 antigen"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"864701","display":"influenza A-California-7-2009-(H1N1)v-like virus vaccine"},{"system":"http://hl7.org/fhir/sid/cvx","version":"20231102","code":"88","display":"influenza virus vaccine, unspecified formulation"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"90630","display":"Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, for intradermal use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"90653","display":"Influenza vaccine, inactivated (IIV), subunit, adjuvanted, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"90654","display":"Influenza virus vaccine, trivalent (IIV3), split virus, preservative-free, for intradermal use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"90655","display":"Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.25 mL dosage, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"90656","display":"Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"90657","display":"Influenza virus vaccine, trivalent (IIV3), split virus, 0.25 mL dosage, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"90658","display":"Influenza virus vaccine, trivalent (IIV3), split virus, 0.5 mL dosage, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"90660","display":"Influenza virus vaccine, trivalent, live (LAIV3), for intranasal use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"90661","display":"Influenza virus vaccine, trivalent (ccIIV3), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"90662","display":"Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"90664","display":"Influenza virus vaccine, live (LAIV), pandemic formulation, for intranasal use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"90666","display":"Influenza virus vaccine (IIV), pandemic formulation, split virus, preservative free, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"90667","display":"Influenza virus vaccine (IIV), pandemic formulation, split virus, adjuvanted, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"90668","display":"Influenza virus vaccine (IIV), pandemic formulation, split virus, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"90672","display":"Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"90673","display":"Influenza virus vaccine, trivalent (RIV3), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"90674","display":"Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"90682","display":"Influenza virus vaccine, quadrivalent (RIV4), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"90685","display":"Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.25 mL dosage, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"90686","display":"Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"90687","display":"Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.25 mL dosage, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"90688","display":"Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"90694","display":"Influenza virus vaccine, quadrivalent (aIIV4), inactivated, adjuvanted, preservative free, 0.5 mL dosage, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"90756","display":"Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2023","code":"G0008","display":"Administration of influenza virus vaccine"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2023","code":"Q2034","display":"Influenza virus vaccine, split virus, for intramuscular use (agriflu)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2023","code":"Q2035","display":"Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2023","code":"Q2036","display":"Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2023","code":"Q2037","display":"Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2023","code":"Q2038","display":"Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2023","code":"Q2039","display":"Influenza virus vaccine, not otherwise specified"}]}}